Staphylococcus aureus Secretes Coagulase and von Willebrand Factor Binding Protein to Modify the Coagulation Cascade and Establish Host Infections
Open Access
- 3 January 2012
- journal article
- review article
- Published by S. Karger AG in Journal of Innate Immunity
- Vol. 4 (2), 141-148
- https://doi.org/10.1159/000333447
Abstract
Clinical isolates of Staphylococcus aureus secrete coagulases, polypeptides that bind to and activate prothrombin, thereby converting fibrinogen to fibrin and promoting the clotting of plasma or blood. Two staphylococcal products, the canonical coagulase (Coa) as well as the recently identified von Willebrand factor binding protein (vWbp), promote similar modifications of the coagulation cascade during host infection. Staphylococcal binding to fibrinogen or fibrin is an important attribute of disease pathogenesis, which leads to the formation of abscesses and bacterial persistence in host tissues and also enables the pathogen to cause lethal sepsis. Circumstantial evidence suggests that the product of coagulase activity, staphylococci captured within a fibrin meshwork, enable this pathogen to disseminate as thromboembolic lesions and to resist opsonophagocytic clearance by host immune cells. In addition, the coagulation products of staphylococci appear to display discrete differences when compared to those of thrombin-mediated coagulation, the latter representing a key innate defense mechanism against many invading pathogens. Preclinical evidence suggests that inactivation or neutralization of coagulases may prevent the pathogenesis of staphylococcal infections, a strategy that could be used to combat the current epidemic of hospital-acquired infections with drug-resistant S. aureus isolates.Keywords
This publication has 98 references indexed in Scilit:
- Preventing Staphylococcus aureus Sepsis through the Inhibition of Its Agglutination in BloodPLoS Pathogens, 2011
- Molecular Mechanisms Affecting Fibrin Structure and StabilityArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Dabigatran Inhibits Staphylococcus aureus Coagulase ActivityJournal of Clinical Microbiology, 2010
- Contribution of Coagulases towards Staphylococcus aureus Disease and Protective ImmunityPLoS Pathogens, 2010
- Pathogen Entrapment by Transglutaminase—A Conserved Early Innate Immune MechanismPLoS Pathogens, 2010
- Coagulation factor XIII variants with altered thrombin activation ratesBiological Chemistry, 2009
- Genetic requirements forStaphylococcus aureusabscess formation and persistence in host tissuesThe FASEB Journal, 2009
- Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombinProceedings of the National Academy of Sciences of the United States of America, 2009
- Simultaneous Activation of Complement and Coagulation by MBL-Associated Serine Protease 2PLOS ONE, 2007
- THE COAGULASE TEST FOR STAPHYLOCOCCI AND ITS CORRELATION WITH THE RESISTANCE OF THE ORGANISMS TO THE BACTERICIDAL ACTION OF HUMAN BLOOD 12JCI Insight, 1942